Volumetric Imaging Follow up of Patients With Liver Metastases of Small Intestinal Neuroendocrine Tumors (NETs).
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Neuroendocrine Tumors
Related studies linked through entity extraction aliases.
Imaging of Patients With Known or Suspected Somatostatin Receptor Positive Neuroendocrine Tumors Using Cu64-DOTATATE
- Status
- COMPLETED
- Phase
- PHASE3
A Study to testABI-009 in Patients With Metastatic, Unresectable, Low or Intermediate Grade Neuroendocrine Tumors of the Lung or Gastroenteropancreatic System
- Status
- TERMINATED
- Phase
- PHASE2
Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin Analogue
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Intra-arterial Lutetium-177-dotatate for Treatment of Patients With Neuro-endocrine Tumor Liver Metastases
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
DOTATOC PET/CT for Imaging NET Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Whole Body Dynamic 68Ga-DOTATOC PET/CT in Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- N/A
Perception of Information and Quality of Life in Neuroendocrine Tumour on Lanreotide Autogel
- Status
- COMPLETED
- Phase
- N/A
Treatment Using 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Optimizing the Interval Between Cycles of PRRT with 177lu-dotatate in Sstr2 Positive Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Status
- RECRUITING
- Phase
- N/A
Efficacy and Safety of 177Lu-Dotatate PRRT in Metastatic GEP-NEN Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Nivolumab With Ipilimumab in Subjects With Neuroendocrine Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Psychosocial Screening for Neuroendocrine Tumor Patients
- Status
- UNKNOWN
- Phase
- N/A
Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide
- Status
- COMPLETED
- Phase
- PHASE4